News Image

Which stocks are moving after the closing bell on Monday?

By Mill Chart

Last update: Jan 23, 2023

Let's have a look at what is happening on the US markets after the closing bell on Monday. Below you can find the top gainers and losers in today's after hours session.

After hours gainers

TickerChangeComment
AXLA53.49%AXCELLA HEALTH INC's (NASDAQ:AXLA) shares rose 53.49% to $0.66 during Monday's after hours session. Earlier today the company had a press release: Axcella Announces Regulatory Path to Registration of AXA1125 for Long COVID Fatigue.
DAVEW32.67%DAVE INC -CW27's (NASDAQ:DAVEW) shares rose 32.67% to $0.04 during Monday's after hours session. Only today these shares were declining by -25.56%, so we see a bit of recovery during the after hours session.
GROM12.16%GROM SOCIAL ENTERPRISES INC's (NASDAQ:GROM) shares rose 12.16% to $2.49 during Monday's after hours session. This is a continuation of today's gain of 29.07%.
HLBZ10.09%HELBIZ INC's (NASDAQ:HLBZ) stock price is advancing with 10.09% to a price of $0.47. Today's gain of 109.0% continues in today's after hours session with 10.09%. A press release (Helbiz Hires ShareIntel for Due Diligence, Advancing in Battle Against Illegal Short Selling) was released earlier today.
INBS8.74%INTELLIGENT BIO SOLUTIONS IN (NASDAQ:INBS) rose 8.74% to $1.12 during Monday's after hours session. Today's gain of 296.0% continues in today's after hours session with 8.74%.
GNS7.01%GENIUS GROUP LTD's (NYSEARCA:GNS) stock price is advancing with 7.01% to a price of $5.04. Also in the regular session NYSEARCA:GNS had a very good day: shares closed with a 45.37% gain. Yesterday the company had a press release: Genius Group 2023 Financial Guidance: $48m - $52m Revenue, Positive EBITDA.
SG6.17%SWEETGREEN INC - CLASS A (NYSE:SG) rose 6.17% to $10.33 during Monday's after hours session. In the last 3 months the share price dropped with 48.65%.
CBAY6.05%CYMABAY THERAPEUTICS INC (NASDAQ:CBAY) rose 6.05% to $7.01 during Monday's after hours session. In the last month the share price increased with 33.27%.
ASXC5.93%ASENSUS SURGICAL INC's (NYSEARCA:ASXC) shares rose 5.93% to $0.72. Shareholders saw the stock price going 99.27% higher in the past month.
IDEX5.82%IDEANOMICS INC (NASDAQ:IDEX) rose 5.82% to $0.19 during Monday's after hours session. In the last 3 months the share price dropped with 32.14%.

Our after hours gainers screener will show you the full list.

Today's after hours losers

TickerChangeComment
VGFC-27.96%VERY GOOD FOOD CO INC/THE's (NASDAQ:VGFC) stock price decreased by 27.96% to $0.04. In the last month the share price dropped with 29.36%.
CKPT-15.89%CHECKPOINT THERAPEUTICS INC's (NASDAQ:CKPT) shares fell 15.89% to $4.5. In the last month the stock gained 39.32%.
PFLT-6.44%PENNANTPARK FLOATING RATE CA's (NYSE:PFLT) stock price decreased by 6.44% to $11.05.
IINN-5.88%INSPIRA TECHNOLOGIES OXY BHN's (NASDAQ:IINN) shares fell 5.88% to $1.76. After today's gain of 49.6%, it goes down with 5.88% in today's after hours session.
JZXN-5.6%JIUZI HOLDINGS INC's (NASDAQ:JZXN) stock price decreased by 5.6% to $0.16. In the last month the share price increased with 42.68%.
ZION-5.58%ZIONS BANCORP NA's (NASDAQ:ZION) stock price decreased by 5.58% to $49.71. yesterday the company released their earnings. Earlier today the company had a press release: Zions Bancorporation, National Association Reports Fourth Quarter Financial Results.
TCRX-5.29%TSCAN THERAPEUTICS INC's (NASDAQ:TCRX) shares fell 5.29% to $1.97. A press release (TScan Therapeutics Announces FDA Clearance of Three Investigational New Drug Applications for the Treatment of Solid Tumors) was released yesterday.
IDAI-5.21%T STAMP INC-CLASS A's (NASDAQ:IDAI) stock price decreased by 5.21% to $0.91. After today's gain of 47.69%, it goes down with 5.21% in today's after hours session.
FRZA-5.0%FORZA X1 INC's (NASDAQ:FRZA) stock price decreased by 5.0% to $1.52. In the last month the stock gained 32.23%.
SNMP-5.0%EVOLVE TRANSITION INFRASTRUC's (NYSEARCA:SNMP) shares fell 5.0% to $0.22 during Monday's after hours session. After running up 53.23% in today's session, NYSEARCA:SNMP is pulling back after hours.

To see the full list of after hours losers you can use our after hours losers screener.

Back

TSCAN THERAPEUTICS INC

NASDAQ:TCRX (3/28/2024, 2:51:43 PM)

7.94

-0.36 (-4.34%)

TCRX News

News Image11 days ago - InvestorPlaceLow-Priced, High-Potential: 7 Cheap Stocks Under $10 to Try Your Luck With

Although lesser-known ideas present high risks, these cheap stocks under $10 could be intriguing for the calculating speculator.

News Image22 days ago - InvestorPlaceTCRX Stock Earnings: TScan Therapeutics Beats EPS, Beats Revenue for Q4 2023

TCRX stock results show that TScan Therapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

News Image22 days ago - BusinessInsiderTCRX Stock Earnings: TScan Therapeutics Beats EPS, Beats Revenue for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips TScan Therapeutics (NASDAQ:TCRX) just reported results for the fourth quarter o...

News Image22 days ago - TScan Therapeutics, Inc.TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
News Image22 days ago - TScan Therapeutics, Inc.TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Presented updated data from ongoing Phase 1 study of TSC-100 and TSC-101 for the treatment of heme malignancies at the Tandem Meetings of ASTCT and CIBMTR; 8/8 (100%) patients in treatment arms are relapse-free and show complete donor chimerism

News Imagea month ago - TScan Therapeutics, Inc.TScan Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
News Imagea month ago - TScan Therapeutics, Inc.TScan Therapeutics Presents Promising Updated Phase 1 Clinical Results on TSC-100 and TSC-101 at the 2024 Tandem Meetings of ASTCT and CIBMTR
News Imagea month ago - TScan Therapeutics, Inc.TScan Therapeutics Presents Promising Updated Phase 1 Clinical Results on TSC-100 and TSC-101 at the 2024 Tandem Meetings of ASTCT and CIBMTR

All eight (100%) treatment-arm patients are relapse-free and have achieved and maintained complete donor chimerism following treatment with TSC-100 or...

News Imagea month ago - TScan Therapeutics, Inc.TScan Therapeutics to Host Virtual KOL Event to Discuss Updated Results from Phase 1 Heme Malignancies Study Presented at the 2024 Tandem Meetings of ASTCT and CIBMTR
News Imagea month ago - TScan Therapeutics, Inc.TScan Therapeutics to Host Virtual KOL Event to Discuss Updated Results from Phase 1 Heme Malignancies Study Presented at the 2024 Tandem Meetings of ASTCT and CIBMTR

TScan’s abstract selected by the Tandem Meetings to receive a Best Abstracts Award Company to discuss the potential implications of initial data from a...

News Image2 months ago - TScan Therapeutics, Inc.TScan Therapeutics Expands Clinical Team with the Appointment of Dawn Pinchasik, M.D., M.S., as Vice President, Clinical Development
News Image2 months ago - TScan Therapeutics, Inc.TScan Therapeutics Expands Clinical Team with the Appointment of Dawn Pinchasik, M.D., M.S., as Vice President, Clinical Development

WALTHAM, Mass., Feb. 06, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the...

TCRX Links
Follow us for more